Related Experiment Video
Updated: Aug 27, 2025

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
CaV1.2 channelopathic mutations evoke diverse pathophysiological mechanisms.
Moradeke A Bamgboye1, Kevin G Herold1, Daiana C O Vieira1
1Department of Physiology, University of Maryland School of Medicine, Baltimore, MD.
Mutations in the CaV1.2 channel's S6 region cause Timothy syndrome (TS) and neurodevelopmental issues. This study reveals distinct effects on channel function, explaining varied symptoms in CaV1.2 channelopathies.
Area of Science:
- Molecular biology
- Biophysics
- Neuroscience
Background:
- The first pathogenic CaV1.2 mutation caused Timothy syndrome (TS), a disorder with cardiac and neurodevelopmental symptoms like autism spectrum disorder (ASD).
- Mutations in the CaV1.2 S6 region are common, but the mechanisms behind neurodevelopmental deficits remain unclear.
- Understanding CaV1.2 channelopathies requires exploring how S6 mutations affect channel function beyond activation.
Purpose of the Study:
- To investigate the diverse mechanisms by which CaV1.2 S6 region mutations impact channel biophysics.
- To elucidate the relationship between specific S6 mutation effects and clinical manifestations, including neurodevelopmental deficits.
- To establish a structure-function framework for CaV1.2 S6 mutations.
Main Methods:
- Whole-cell patch clamp electrophysiology.
- Quantitative calcium imaging.
- Single channel recordings.
Main Results:
- CaV1.2 S6 region mutations independently affect channel activation, voltage-dependent inactivation (VDI), and Ca2+-dependent inactivation (CDI).
- Mechanisms for altered CDI include changes in channel gating and potential disruption of inactivation signal transduction.
- Distinct biophysical defects correlate with specific clinical phenotypes observed in patients.
Conclusions:
- CaV1.2 S6 mutations have varied and separable impacts on channel function, contributing to the complex clinical spectrum of channelopathies.
- This work provides a framework for understanding how S6 mutations lead to distinct cardiac and neurodevelopmental symptoms.
- Further research into these biophysical defects can inform therapeutic strategies for CaV1.2-related disorders.
More Related Videos
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Mechanically-gated Ion Channels
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
G-Protein Gated Ion Channels
Sensory...

